FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090866193> ?p ?o ?g. }

• W2090866193 endingPage "334" @default.
• W2090866193 startingPage "328" @default.
• W2090866193 abstract "Insulin-like growth factor binding protein-5 (IGFBP-5) and thrombospondin-1 (TS-1) are both present in extracellular matrix (ECM). Both proteins have been shown to bind to one another with high affinity. The purpose of these studies was to determine how the interaction between IGFBP-5 and TS-1 modulates IGF-I actions in porcine aortic smooth muscle cells (pSMC) in culture. The addition of increasing concentrations of TS-1 to pSMC cultures enhanced the protein synthesis and cell migration responses to IGF-I; whereas the addition of IGFBP-5 alone resulted in minimal changes. In contrast, the addition of IGFBP-5 to cultures that were also exposed to IGF-I and TS-1 resulted in inhibition of protein synthesis. When the cell migration response was assessed, the response to IGF-I plus TS-1 was also significantly inhibited by the addition of IGFBP-5, whereas 1.0 microg/ml of IGFBP-5 alone had no effect on the response to IGF-I. To determine the molecular mechanism by which this inhibition occurred, a mutant form of IGFBP-5 that does not bind to IGF-I was tested. This mutant was equipotent compared to native IGFBP-5 in its ability to inhibit both protein synthesis and cell migration responses to IGF-I plus TS-1 thus excluding the possibility that IGFBP-5 was inhibiting the response to TS-1 and IGF-I by inhibiting IGF-I binding to the IGF-I receptor. To determine if an interaction between TS-1 and IGFBP-5 was the primary determinant of the inhibitory effect of IGFBP-5, an IGFBP-5 mutant that bound poorly to TS-1 was utilized. The addition of 1.0 microg/ml of this mutant did not inhibit the protein synthesis or cell migration responses to IGF-I plus TS-1. To determine the mechanism by which IGFBP-5 binding to TS-1 inhibited cellular responses to TS-1 plus IGF-I, TS-1 binding to integrin associated protein (IAP) was assessed. The addition of IGFBP-5 (1.0 microg/ml) inhibited TS-1-IAP association. In contrast, a mutant form of IGFBP-5 that bound poorly to TS-1 had a minimal effect on TS-1 binding to IAP. Further analysis showed that IGFBP-5 addition altered the ability of TS-1 to modulate the SHPS-1/IAP interaction. When the IGFBP-5 mutant that did not bind to IGF-I was incubated with TS-1 and IGF-I, it inhibited the capacity of TS-1 to enhance the IGF-I receptor phosphorylation and MAP kinase activation in response to IGF-I. In contrast, the IGFBP-5 mutant that did not bind to TS-1 had no effect on IGF-I stimulated IGF-I receptor phosphorylation or MAP kinase activation. These results indicate that IGFBP-5 inhibits the binding of TS-1 to IAP, and this results in an alteration of the ability of TS-1 to modulate the disruption of the IAP/SHPS-1 interaction which leads to attenuation of the ability of TS-1 to enhance cellular responsiveness to IGF-I." @default.
• W2090866193 created "2016-06-24" @default.
• W2090866193 creator A5000288481 @default.
• W2090866193 creator A5005662849 @default.
• W2090866193 creator A5039368198 @default.
• W2090866193 creator A5059093014 @default.
• W2090866193 creator A5061686944 @default.
• W2090866193 date "2005-01-01" @default.
• W2090866193 modified "2023-09-25" @default.
• W2090866193 title "Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions" @default.
• W2090866193 cites W1605635614 @default.
• W2090866193 cites W1964757048 @default.
• W2090866193 cites W1965909442 @default.
• W2090866193 cites W1981279611 @default.
• W2090866193 cites W1998785413 @default.
• W2090866193 cites W2000394884 @default.
• W2090866193 cites W2011016741 @default.
• W2090866193 cites W2015843482 @default.
• W2090866193 cites W2016391435 @default.
• W2090866193 cites W2018633162 @default.
• W2090866193 cites W2022665089 @default.
• W2090866193 cites W2024642928 @default.
• W2090866193 cites W2034967926 @default.
• W2090866193 cites W2039604806 @default.
• W2090866193 cites W2048106517 @default.
• W2090866193 cites W2064102688 @default.
• W2090866193 cites W2075386107 @default.
• W2090866193 cites W2077388974 @default.
• W2090866193 cites W2083359402 @default.
• W2090866193 cites W2083434885 @default.
• W2090866193 cites W2083891157 @default.
• W2090866193 cites W2099564933 @default.
• W2090866193 cites W2100577875 @default.
• W2090866193 cites W2101650166 @default.
• W2090866193 cites W2111144663 @default.
• W2090866193 cites W2111584985 @default.
• W2090866193 cites W2118678876 @default.
• W2090866193 cites W2121968060 @default.
• W2090866193 cites W2133725782 @default.
• W2090866193 cites W2136304337 @default.
• W2090866193 cites W2140119451 @default.
• W2090866193 cites W2154500798 @default.
• W2090866193 cites W2158979977 @default.
• W2090866193 cites W2163286721 @default.
• W2090866193 cites W2165483382 @default.
• W2090866193 cites W2168610043 @default.
• W2090866193 doi "https://doi.org/10.1002/jcp.20343" @default.
• W2090866193 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15700281" @default.
• W2090866193 hasPublicationYear "2005" @default.
• W2090866193 type Work @default.
• W2090866193 sameAs 2090866193 @default.
• W2090866193 citedByCount "13" @default.
• W2090866193 countsByYear W20908661932015 @default.
• W2090866193 countsByYear W20908661932017 @default.
• W2090866193 countsByYear W20908661932020 @default.
• W2090866193 countsByYear W20908661932021 @default.
• W2090866193 countsByYear W20908661932023 @default.
• W2090866193 crossrefType "journal-article" @default.
• W2090866193 hasAuthorship W2090866193A5000288481 @default.
• W2090866193 hasAuthorship W2090866193A5005662849 @default.
• W2090866193 hasAuthorship W2090866193A5039368198 @default.
• W2090866193 hasAuthorship W2090866193A5059093014 @default.
• W2090866193 hasAuthorship W2090866193A5061686944 @default.
• W2090866193 hasConcept C104317684 @default.
• W2090866193 hasConcept C109523444 @default.
• W2090866193 hasConcept C126322002 @default.
• W2090866193 hasConcept C143065580 @default.
• W2090866193 hasConcept C167814343 @default.
• W2090866193 hasConcept C170493617 @default.
• W2090866193 hasConcept C185592680 @default.
• W2090866193 hasConcept C189165786 @default.
• W2090866193 hasConcept C2775960820 @default.
• W2090866193 hasConcept C2780378035 @default.
• W2090866193 hasConcept C2780394083 @default.
• W2090866193 hasConcept C2780689927 @default.
• W2090866193 hasConcept C2910422434 @default.
• W2090866193 hasConcept C502942594 @default.
• W2090866193 hasConcept C54355233 @default.
• W2090866193 hasConcept C553089730 @default.
• W2090866193 hasConcept C55493867 @default.
• W2090866193 hasConcept C55728118 @default.
• W2090866193 hasConcept C71924100 @default.
• W2090866193 hasConcept C81885089 @default.
• W2090866193 hasConcept C86803240 @default.
• W2090866193 hasConcept C95444343 @default.
• W2090866193 hasConcept C99194444 @default.
• W2090866193 hasConceptScore W2090866193C104317684 @default.
• W2090866193 hasConceptScore W2090866193C109523444 @default.
• W2090866193 hasConceptScore W2090866193C126322002 @default.
• W2090866193 hasConceptScore W2090866193C143065580 @default.
• W2090866193 hasConceptScore W2090866193C167814343 @default.
• W2090866193 hasConceptScore W2090866193C170493617 @default.
• W2090866193 hasConceptScore W2090866193C185592680 @default.
• W2090866193 hasConceptScore W2090866193C189165786 @default.
• W2090866193 hasConceptScore W2090866193C2775960820 @default.
• W2090866193 hasConceptScore W2090866193C2780378035 @default.
• W2090866193 hasConceptScore W2090866193C2780394083 @default.
• W2090866193 hasConceptScore W2090866193C2780689927 @default.

• next